Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec 31;20(1):2386730.
doi: 10.1080/15476278.2024.2386730. Epub 2024 Aug 4.

A Review of the Risk Factors and Approaches to Prevention of Post-Reperfusion Syndrome During Liver Transplantation

Affiliations
Review

A Review of the Risk Factors and Approaches to Prevention of Post-Reperfusion Syndrome During Liver Transplantation

Qian Gao et al. Organogenesis. .

Abstract

Post-reperfusion syndrome (PRS) is a severe and highly lethal syndrome that occurs after declamping the portal vein forceps during liver transplantation. It is marked by severe hemodynamic disturbances manifested by decreased mean arterial pressure, increased heart rate and elevated pulmonary artery pressure. The complex pathogenesis of PRS remains understudied. It is generally believed to be related to the large amount of acidic, cold blood that enters the circulation after release of the portal clamp. This blood is rich in oxygen-free radicals and metabolic toxins, which not only aggravate the ischemia-reperfusion injury of the liver but also further attack the systemic organs indiscriminately. Considering the range of possible adverse prognoses including acute kidney injury, delirium and graft nonfunction, it is imperative that clinicians increase their awareness and prevention of PRS. The aim of this article is to review the current risk factors, pathophysiological mechanisms and prevention strategies for PRS.

Keywords: Ischemia; liver transplantation; reperfusion injury; review; risk factors.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
The model of liver transplantation progress. (a) Acquire liver graft from donation after cardiac death or donation after brain death then repair it. (b) Remove the deceased liver from recipient. (c) Implant the liver graft into recipient. (d) Declamping the portal vein forceps into new hepatic phase.
Figure 2.
Figure 2.
The production of ROS during IRI. (a) With the massive consumption of ATP, XDH changes into XOD. Accumulating large amounts of xanthine. (b) BH4 is heavily consumed, prompting the uncoupling of the NOS. (c) Activated Kupffer cells also promote ROS production.

References

    1. Aggarwal S, Kang Y, Freeman J, Fortunato F, Pinsky M.. Postreperfusion syndrome: cardiovascular collapse following hepatic reperfusion during liver transplantation. Transplant Proc. 1987;19:54–18. - PubMed
    1. Hilmi I, Horton C, Planinsic R, Sakai T, Nicolau-Raducu R, Damian D, Gligor S, Marcos A. The impact of postreperfusion syndrome on short-term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. 2008;14(4):504–08. doi: 10.1002/lt.21381. - DOI - PubMed
    1. Lee J, Yoo Y, Lee J, Park Y, Ryu H. Sevoflurane versus desflurane on the incidence of postreperfusion syndrome during living donor liver transplantation: a randomized controlled trial. Transplantation. 2016;100(3):600–06. doi: 10.1097/tp.0000000000000874. - DOI - PubMed
    1. Ruiz de Azúa-López Z, Naranjo-Izurieta J, Lameirao J, Martín-Villén L, Porras-López M, Palomo-Lopez N, Vilchez-Arenas A, Egea-Guerrero JJ. Cold ischemia time as a factor in post-transplantation complications for orthotopic hepatic transplantation. Transplant Proc. 2018;50(2):637–39. doi: 10.1016/j.transproceed.2017.11.054. - DOI - PubMed
    1. Blanot S, Gillon M, Ecoffey C, Lopez I. Circulating endotoxins during orthotopic liver transplantation and post-reperfusion syndrome. Lancet (Lond, Engl). 1993;342(8875):859–60. doi: 10.1016/0140-6736(93)92715-6. - DOI - PubMed

LinkOut - more resources